|
Key Manuscripts
The safety and effects of the beta-blocker, nadolol, in mild asthma: An open-label pilot study
Nicola A. Hanania, Supria Singh, Rami El-Walia, Michael Flashner, Amie E. Franklin, William J. Garner, Burton F. Dickey, Sergio Parra, Stephen Ruoss, Felix Shardonofsky, Brian J. O'Connor, Clive Page, Richard A. Bond
Pulmonary Pharmacology & Therapeutics, 2007
β2-Adrenoceptor signaling is required for the development of an asthma phenotype in a murine model
Long P. Nguyen, Rui Lin, Sergio Parra, Ozozoma Omoluabi, Nicola A. Hanania, Michael J. Tuvim, Brian J. Knoll, Burton F. Dickey, and Richard A. Bond
Proceedings from the National Academy of Sciences (PNAS), 2008
Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model.
Nguyen LP, Omoluabi O, Parra S, Frieske JM, Clement C, Ammar-Aouchiche Z, Ho SB, Ehre C, Kesimer M, Knoll BJ, Tuvim MJ, Dickey BF, Bond RA
American Journal of Respiratory Cell & Molecular Biology, 2008
Impact of Cardioselective β-Blockers on Mortality in Patients with Chronic Obstructive Pulmonary Disease and Atherosclerosis
Yvette R. B. M. van Gestel, Sanne E. Hoeks, Don D. Sin, Gijs M. J. M. Welten, Olaf Schouten, Han J. Witteveen, Cihan Simsek, Henk Stam, Frans W. Mertens, Jeroen J. Bax, Ron T. van Domburg, and Don Poldermans
Am J Respir Crit Care Med Vol 178, 2008
Changes in β2-adrenoceptor and other signaling proteins produced by chronic administration of 'β-blockers' in a murine asthma model
Rui Lin, Hui Peng, Long P. Nguyen, Noor B. Dudekula, Felix Shardonofsky, Brian J. Knoll, Sergio Parra, Richard A. Bond
Proceedings from the National Academy of Sciences (PNAS), 2007
|
